Amy M. Scott-Billman, Vice President of Global Regulatory Strategy for Immunotherapeutics at GlaxoSmithKline Biologicals, to Give Keynote Presentation at GTCbio’s 5th Modern Drug Discovery & Development Summit on October 14-16, 2009 in San Diego, CA
Amy Scott-Billman, Vice President of Global Regulatory Strategy for Immunotherapeutics at GlaxoSmithKline Biologicals, is to give a keynote presentation concerning regulatory considerations & challenges for immunotherapeutic/diagnostic co-development at GTCbio’s 5th Modern Drug Discovery & Development Summit, on October 14th-16th, 2009, in San Diego, CA.
View full press release